Pharmascroll Research And Consulting Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.13 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 277.08%
- Profit Growth 342.94%
- Ebitda 423.36%
- Net Worth 2287.33%
- Total Assets 1100.10%
About Pharmascroll Research And Consulting
Pharmascroll Research And Consulting Private Limited (PRACPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 June 2017 (Seven years and seven months 24 days old ). Its registered office is in Rangareddy, Telangana, India.
The Corporate was formerly known as Pharmascroll Resarch And Consulting Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Bhawna Gupta, Sahil Singla, Vandana Nainwal, and One other member serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U93000TG2017PTC117856
-
Company No.
117856
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jun 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharmascroll Research And Consulting?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vandana Nainwal
|
Director | 31-Dec-2018 | Current |
|
Sahil Singla
|
Director | 25-Apr-2024 | Current |
|
Bhawna Gupta
|
Director | 21-Jun-2017 | Current |
|
Ramesh Nainwal
|
Director | 25-Apr-2024 | Current |
Financial Performance of Pharmascroll Research And Consulting.
Pharmascroll Research And Consulting Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 277.08% increase. The company also saw a substantial improvement in profitability, with a 342.94% increase in profit. The company's net worth Soared by an impressive increase of 2287.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmascroll Research And Consulting?
In 2023, Pharmascroll Research And Consulting had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmascroll Research And Consulting?
Pharmascroll Research And Consulting has a workforce of 21 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmascroll Research And Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmascroll Research And Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
